ArrowMark Colorado Holdings Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Steris
STE
|
+$61.6M |
| 2 |
Halozyme
HALO
|
+$54.3M |
| 3 |
CarGurus
CARG
|
+$52.2M |
| 4 |
Viper Energy
VNOM
|
+$42.1M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$40.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Frontdoor
FTDR
|
+$101M |
| 2 |
MNTV
Momentive Global Inc. Common Stock
MNTV
|
+$80.6M |
| 3 |
ON Semiconductor
ON
|
+$68.3M |
| 4 |
TriNet
TNET
|
+$65.8M |
| 5 |
DOCU
DocuSign
DOCU
|
+$54.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.41% |
| 2 | Technology | 22.03% |
| 3 | Consumer Discretionary | 17.06% |
| 4 | Industrials | 15.21% |
| 5 | Communication Services | 6.66% |
Similar funds
ArrowMark Colorado Holdings's Q1 2023 Portfolio in Review
As of Q1 2023, ArrowMark Colorado Holdings held 334 positions worth $8.8B, up 5.1% from $8.38B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
ArrowMark Colorado Holdings withdrew a net $361M in Q1 2023, closing 28 positions and reducing 110 holdings. Its most notable exit was DocuSign, an estimated $54.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, ArrowMark Colorado Holdings opened a new position in Halozyme worth $44.2M.
- ArrowMark Colorado Holdings's largest Q1 2023 buy was Halozyme: 1,156,598 shares worth $44.2M.
- ArrowMark Colorado Holdings added most to Steris in Q1 2023, an estimated $61.6M increase.
- ArrowMark Colorado Holdings's biggest Q1 2023 reduction was Frontdoor, cutting an estimated $101M.
- ArrowMark Colorado Holdings fully exited DocuSign in Q1 2023, selling an estimated $54.7M.
- ArrowMark Colorado Holdings's ten largest holdings make up 24% of its $8.8B portfolio in Q1 2023.
- ArrowMark Colorado Holdings opened 30 new positions and closed 28 in Q1 2023.
- ArrowMark Colorado Holdings's portfolio value rose 5.1% quarter-over-quarter to $8.8B.
Based on ArrowMark Colorado Holdings's 13F filing for Q1 2023, filed 15 May 2023.